Cereno Scientific ABFRA:4A1 -1.74%33 Operating Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:4A1 with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 955 Drug Manufacturers companies, Cereno Scientific AB ranks worse than 104711.94% on this metric.
The historical rank and industry rank for Cereno Scientific AB's Operating Margin % or its related term are showing as below:
FRA:4A1's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.45 * Ranked among companies with meaningful Operating Margin % only.
Cereno Scientific AB's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Cereno Scientific AB has never been profitable in the past 3 years. It lost money every year.
Cereno Scientific AB (FRA:4A1) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Cereno Scientific AB Operating Margin % Related Terms
Cereno Scientific AB Operating Margin % Historical Data
* Premium members only.
The historical data trend for Cereno Scientific AB's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cereno Scientific AB Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Cereno Scientific AB's Operating Margin % falls into.
Cereno Scientific AB Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Cereno Scientific AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cereno Scientific AB (FRA:4A1) has a Operating Margin % of 0.00% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Cereno Scientific AB and its competitors. According to the industry distribution chart, Cereno Scientific AB ranks #999999 out of 955 companies in the Drug Manufacturers industry.
Is Cereno Scientific AB's Operating Margin % too high?
Cereno Scientific AB's current Operating Margin % is 0.00%. Based on the distribution chart, Cereno Scientific AB ranks #999999 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cereno Scientific AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Cereno Scientific AB's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Cereno Scientific AB ranks #999999 out of 955 companies for Operating Margin %. This places Cereno Scientific AB in the lower half of its industry. The industry median Operating Margin % is 7.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Cereno Scientific AB and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cereno Scientific AB's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cereno Scientific AB stock overvalued right now?
Cereno Scientific AB (FRA:4A1) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. Cereno Scientific AB's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Cereno Scientific AB (FRA:4A1), the current Operating Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. It also evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.
33GF Score
Get the complete analysis for FRA:4A1
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4A1 has been successfully added to your 
